Concepedia

Contribution of either YY1 or BclXL-induced inhibition by the NO-donor DETANONOate in the reversal of drug resistance, both in vitro and in vivo. YY1 and BclXL are overexpressed in prostate cancer

Sara Huerta‐Yépez, Stavroula Baritaki, Guillermina Baay-Guzmán, Marco Antonio Hernández-Luna, Angeles Hernandez-Cueto, Mario I. Vega, Benjamin Bonavida

Nitric Oxide · 2012 · 68 citations · 18 references

DOI

Concepts

References

18

A Method for Testing for Synergy with Any Number of Agents

M. C. Berenbaum · The Journal of Infectious Diseases · 1978 · 734 citations

, , +13

A nitric oxide donor induces neurogenesis and reduces functional deficits after stroke in rats

Ruilan Zhang, Li Zhang, Zhenggang Zhang et al. · Annals of Neurology · 2001 · 251 citations

, , +15

Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa

Yang Meng, Wenhua Tang, Yao Dai et al. · Molecular Cancer Therapeutics · 2008 · 185 citations · Full text

, , +14

Bcl-xL in prostate cancer cells: effects of overexpression and down-regulation on chemosensitivity.

Irina V. Lebedeva, Robert F. Rando, Joshua O. Ojwang et al. · PubMed · 2000 · 171 citations

, , +15

Nitric oxide sensitizes prostate carcinoma cell lines to TRAIL-mediated apoptosis via inactivation of NF-κB and inhibition of Bcl-xL expression

Sara Huerta‐Yépez, Mario I. Vega, Ali R. Jazirehi et al. · Oncogene · 2004 · 164 citations

, , +17